Sandoo Pharmaceuticals
Sandoo Pharmaceuticals, a leading player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2005, the company has established itself as a key innovator in the development of high-quality generic and specialty pharmaceuticals, focusing on therapeutic areas such as oncology, cardiology, and infectious diseases. Sandoo Pharmaceuticals is renowned for its commitment to research and development, which has led to the successful launch of several unique formulations that address unmet medical needs. With a strong market position, the company has achieved notable milestones, including strategic partnerships and a robust portfolio of patented products. Sandoo Pharmaceuticals continues to enhance its reputation as a trusted provider of effective healthcare solutions, dedicated to improving patient outcomes globally.
DitchCarbon Score
How does Sandoo Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sandoo Pharmaceuticals's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sandoo Pharmaceuticals's reported carbon emissions
Sandoo Pharmaceuticals, headquartered in CN, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that many pharmaceutical companies are increasingly focusing on sustainability and climate commitments, often aligning with industry standards to reduce their environmental impact. Sandoo Pharmaceuticals may be engaging in similar initiatives, but specific details are not available at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sandoo Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
